They suggest that APCL uses the 15R region of APC to target β-catenin for degradation and offer a plausible explanation as to why APCL is not mutated and why the truncating mutations in APC almost always lead to the retention of a fragment of minimal length in colon tumour cells. Here, APC2 is linked to colonic neoplasm.